MedTech SuperConnector (MTSC)
MedTech accelerator launch event 25 June 2018
Lead higher education institution (HEI): Imperial College London
HEI partners: Buckinghamshire New university, Institute of Cancer Research, Queen Mary University of London, Royal College of Art, Royal College of Music, Royal Veterinary College, The Francis Crick Institute
CCF follow on funding award: £3,457,408
MedTech SuperConnector (MTSC), an accelerator programme founded in 2018 to empower early-career researchers to translate academic insights from the arts and sciences into early-stage medical technologies, has not only supported new medical technologies but used experimentation to identify best practice in entrepreneurship education and MedTech acceleration.
In the four previous cohorts, MTSC has experimented with technology- and challenge-led models for sourcing promising innovation, technology, and researchers. Its findings have been disseminated beyond the consortium of the MTSC and supported the development of industry and HEI entrepreneurship initiatives.
- Ventures employing 24+ people
- 11 startups formed
- 15 patents filed
- £7.24m+ raised in VC and grants
- The Royal College of Music commercialising its first ever technology venture
- Sharing findings with the CRUK Advisory Board for entrepreneurship, Hamlyn Centre for Surgical Innovation, and London In Vitro Diagnostics
MTSC’s mission to establish a new MedTech hub while creating and sharing best acceleration practice has never been more relevant in the face of the UK’s current MedTech competitivity and localisation challenges. The CCF extension funding will allow for the delivery of a new approach to MedTech acceleration at a national scale, the inclusion of an innovation seed fund and world leading digital learning content.